Effect of adjuvant therapy of transfer factor oral solution on the infection process of children with Mycoplasma pneumonia
Objective: To explore the effect of adjuvant transfer factor oral solution therapy on the infection process of children with mycoplasma pneumonia. Methods: A total of 164 children with mycoplasma pneumonia who were treated in our hospital between January 2017 and January 2018 were selected as the...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Editorial Board of Journal of Hainan Medical University
2018-07-01
|
| Series: | Journal of Hainan Medical University |
| Subjects: | |
| Online Access: | http://www.hnykdxxb.com/PDF/201814/15.pdf |
| Summary: | Objective: To explore the effect of adjuvant transfer factor oral solution therapy on the
infection process of children with mycoplasma pneumonia. Methods: A total of 164 children
with mycoplasma pneumonia who were treated in our hospital between January 2017 and
January 2018 were selected as the research subjects and divided into control group (n=82)
and transfer factor oral solution group (n=82) by random number table method. Control group
received clinical routine therapy for children with mycoplasma pneumonia, transfer factor
oral solution group received both routine therapy and transfer factor oral solution therapy, and
both groups were treated for consecutive 1 week. The differences in infection-related index
levels were compared between the two groups before and after treatment. Results: Before
treatment, the differences in serum levels of inflammatory factors, coagulation indexes and
immunoglobulins were not statistically significant between the two groups. After 1 week of
treatment, serum inflammatory factors IL-2, IL-13 and IL-18 contents of transfer factor oral
solution group were lower than those of control group; serum coagulation index FIB level was
lower than that of control group whereas PT and APTT levels were higher than those of control
group; serum immunoglobulins IgG, IgA and IgM contents were lower than those of control
group. Conclusion: Adjuvant transfer factor oral solution therapy can effectively relieve the
systemic inflammatory response and reduce the coagulation system and humoral immune
system function damage in children with mycoplasma pneumonia. |
|---|---|
| ISSN: | 1007-1237 1007-1237 |